News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
792,689 Results
Type
Article (55575)
Company Profile (330)
Press Release (736771)
Multimedia
Podcasts (121)
Webinars (23)
Section
Business (221687)
Career Advice (2943)
Deals (37821)
Drug Delivery (141)
Drug Development (87165)
Employer Resources (186)
FDA (17527)
Job Trends (16149)
News (375020)
Policy (36235)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2946)
Academic (1)
Accelerated approval (39)
Adcomms (34)
Allergies (163)
Alliances (53723)
ALS (188)
Alzheimer's disease (1795)
Antibody-drug conjugate (ADC) (359)
Approvals (17743)
Artificial intelligence (597)
Autoimmune disease (178)
Automation (46)
Bankruptcy (392)
Best Places to Work (12232)
BIOSECURE Act (21)
Biosimilars (206)
Biotechnology (211)
Bladder cancer (174)
Brain cancer (66)
Breast cancer (683)
Cancer (5221)
Cardiovascular disease (452)
Career advice (2498)
Career pathing (41)
CAR-T (305)
CDC (62)
Celiac Disease (2)
Cell therapy (818)
Cervical cancer (38)
Clinical research (74188)
Collaboration (1879)
Company closure (4)
Compensation (1207)
Complete response letters (74)
COVID-19 (2937)
CRISPR (104)
C-suite (954)
Cystic fibrosis (149)
Data (6610)
Decentralized trials (2)
Denatured (33)
Depression (156)
Diabetes (540)
Diagnostics (7191)
Digital health (52)
Diversity (13)
Diversity, equity & inclusion (46)
Drug discovery (285)
Drug pricing (217)
Drug shortages (31)
Duchenne muscular dystrophy (256)
Earnings (96340)
Editorial (68)
Employer branding (24)
Employer resources (164)
Events (128699)
Executive appointments (1062)
FDA (20818)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (12)
Frontotemporal dementia (25)
Funding (1594)
Gene editing (220)
Generative AI (53)
Gene therapy (678)
GLP-1 (1108)
Government (5184)
Grass and pollen (8)
Guidances (387)
Healthcare (20321)
HIV (74)
Huntington's disease (51)
IgA nephropathy (89)
Immunology and inflammation (295)
Immuno-oncology (74)
Indications (132)
Infectious disease (3244)
Inflammatory bowel disease (212)
Inflation Reduction Act (15)
Influenza (130)
Intellectual property (265)
Interviews (567)
IPO (17329)
IRA (57)
Job creations (4261)
Job search strategy (2036)
JPM (67)
Kidney cancer (20)
Labor market (88)
Layoffs (620)
Leadership (43)
Legal (9019)
Liver cancer (100)
Longevity (19)
Lung cancer (708)
Lymphoma (393)
Machine learning (46)
Management (63)
Manufacturing (868)
MASH (181)
Medical device (14626)
Medtech (14691)
Mergers & acquisitions (21598)
Metabolic disorders (1412)
mRNA (187)
Multiple sclerosis (178)
NASH (23)
Neurodegenerative disease (366)
Neuropsychiatric disorders (104)
Neuroscience (3180)
Neurotech (1)
NextGen: Class of 2026 (7180)
Non-profit (4952)
Now hiring (69)
Obesity (677)
Opinion (329)
Ovarian cancer (173)
Pain (221)
Pancreatic cancer (248)
Parkinson's disease (311)
Partnered (33)
Patents (536)
Patient recruitment (542)
Peanut (65)
People (64602)
Pharmaceutical (68)
Pharmacy benefit managers (32)
Phase 1 (23046)
Phase 2 (32474)
Phase 3 (24344)
Pipeline (5984)
Policy (339)
Postmarket research (2968)
Preclinical (9881)
Press Release (71)
Prostate cancer (267)
Psychedelics (59)
Radiopharmaceuticals (306)
Rare diseases (982)
Real estate (6655)
Recruiting (77)
Regulatory (26889)
Reports (54)
Research institute (2660)
Resumes & cover letters (461)
Rett syndrome (30)
RNA editing (18)
RSV (86)
Schizophrenia (164)
Series A (267)
Series B (201)
Service/supplier (15)
Sickle cell disease (109)
Special edition (27)
Spinal muscular atrophy (171)
Sponsored (45)
Startups (3961)
State (2)
Stomach cancer (21)
Supply chain (113)
Tariffs (95)
The Weekly (86)
Vaccines (1135)
Venture capital (97)
Weight loss (450)
Women's health (100)
Worklife (22)
Date
Today (178)
Last 7 days (933)
Last 30 days (2955)
Last 365 days (31497)
2026 (5301)
2025 (31714)
2024 (36867)
2023 (41850)
2022 (53157)
2021 (57859)
2020 (56709)
2019 (49914)
2018 (37815)
2017 (34755)
2016 (34879)
2015 (41055)
2014 (35374)
2013 (30825)
2012 (32824)
2011 (33433)
2010 (31843)
Location
Africa (960)
Alabama (89)
Alaska (7)
Arizona (337)
Arkansas (15)
Asia (44464)
Australia (8006)
California (11955)
Canada (3423)
China (1196)
Colorado (502)
Connecticut (515)
Delaware (355)
Europe (99311)
Florida (1777)
Georgia (388)
Hawaii (3)
Idaho (65)
Illinois (948)
India (75)
Indiana (552)
Iowa (23)
Japan (458)
Kansas (130)
Kentucky (44)
Louisiana (29)
Maine (84)
Maryland (1463)
Massachusetts (8678)
Michigan (365)
Minnesota (667)
Mississippi (7)
Missouri (140)
Montana (36)
Nebraska (29)
Nevada (131)
New Hampshire (86)
New Jersey (3200)
New Mexico (31)
New York (3140)
North Carolina (1616)
North Dakota (10)
Northern California (5853)
Ohio (363)
Oklahoma (21)
Oregon (44)
Pennsylvania (2388)
Puerto Rico (25)
Rhode Island (51)
South America (1333)
South Carolina (69)
South Dakota (1)
Southern California (4659)
Tennessee (183)
Texas (1847)
United States (42680)
Utah (361)
Vermont (1)
Virginia (283)
Washington D.C. (86)
Washington State (975)
West Virginia (4)
Wisconsin (123)
Wyoming (2)
792,689 Results for "prophase labs inc formerly known as quigley corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
ProPhase Labs Initiates Potential Sale or Strategic Partnership of BE-Smart™ and Advances Crown Medical Collections Initiative
February 3, 2026
·
8 min read
Press Releases
ProPhase Labs, Inc. to Present Third Quarter 2025 Financial Results on November 19
November 19, 2025
·
1 min read
Press Releases
ProPhase Labs to Present at the 2025 ThinkEquity Conference
October 27, 2025
·
1 min read
Press Releases
ProPhase Labs Announces Publication of BE-Smart Esophageal Cancer Study in the Official Journal of the American College of Gastroenterology
October 30, 2025
·
7 min read
Press Releases
ProPhase Labs Inc. to Present Second Quarter 2025 Financial Results on August 13, 2025
August 12, 2025
·
1 min read
Press Releases
ProPhase Labs Inc. to Participate in Renmark’s Virtual Non-Deal Roadshow Series on Thursday, September 4, 2025
September 4, 2025
·
2 min read
Press Releases
ProPhase Labs Announces Study Validating BE-Smart Esophageal Cancer Test Accepted by Journal of Clinical Gastroenterology and Hepatology
October 23, 2025
·
7 min read
Press Releases
ProPhase Labs Announces Full USPTO Approval for Issuance of U.S. Patent Protecting Esophageal Adenocarcinoma Risk Assessment
August 13, 2025
·
5 min read
Press Releases
ProPhase Labs, Inc. Receives Additional 180 Day Extension from Nasdaq to Regain Compliance with Minimum Bid Price Rule
June 26, 2025
·
5 min read
Press Releases
ProPhase Labs Announces Financial Results for the Three and Six Months Ended June 30, 2025
August 14, 2025
·
20 min read
1 of 79,269
Next
